| ACC | Acetyl-CoA carboxylase |
| ADM | Antidiabetic medication |
| AMPK | AMPactivated protein kinase |
| AKT | Serine/threonine-specific protein kinase |
| CI | Confidence interval |
| DDD | Defined daily dose |
| FinDM | Diabetes in Finland |
| HCC | Hepatocellular carcinoma |
| HMG-CoA | 3-hydroxy-3-methyl-glutarylcoenzyme A |
| HR | Hazard ratio |
| IGF-1 | Insulin-like growth factor 1 |
| mTOR | Mammalian target of rapamycin |
| OS | Overall survival |
| PI3K | Phosphatidylinositol-3-kinase |
| p53 | Tumor protein p53 |
| STAT3 | Signal transducer and activator of transcription 3 |
| T2D | Type 2 diabetes mellitus |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.